Fig. 5
From: ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma
High levels of ATF2 predicts poor prognosis of RCC patients. a & b & c Comparison of ATF2 expression in human RCC tissues with diameter > 4 cm or ≤ 4 cm (a), RCC tissues with or without tumor thrombus (b), RCC tissues with or without tumor metastasis (c) determined by immunohistochemistry. The horizontal lines in the box plots represent the median, the boxes represent the interquartile range, and the whiskers represent the 2.5th and 97.5th percentiles. d Patients in comparative ATF2 high group (n = 102) had lower overall survival time than those in comparative ATF2 low group (n = 103) (P = 0.017). e Patients in comparative ATF2 high group (n = 102) had lower disease-free survival time than those in comparative ATF2 low group (n = 103) (P = 0.031)